Singular Genomics Systems, Inc. (OMIC) News

Singular Genomics Systems, Inc. (OMIC): $4.02

0.20 (+5.24%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter OMIC News Items

OMIC News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest OMIC News From Around the Web

Below are the latest news stories about Singular Genomics Systems Inc that investors may wish to consider to help them evaluate OMIC as an investment opportunity.

16 unloved stocks ripe for a rally: Bank of America

These IPO stocks look very oversold, argues Bank of America strategists.

Yahoo | January 18, 2022

Singular Genomics Systems (OMIC) presents at 40th JPMorgan Annual Healthcare Conference (Slideshow)

No summary available.

Seeking Alpha | January 11, 2022

Singular Genomics Partners with Lexogen to Enable RNA Library Prep for the G4 Sequencing Platform

This partnership integrates G4’s accuracy, speed, flexibility and power with Lexogen’s expertise in RNA library preparation kits to empower specialized workflows for customers.LA JOLLA, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced a partnership with Lexogen to demonstrate the G4 sequencing platform’s compatibil

Yahoo | January 10, 2022

Singular Genomics Partners with Dovetail Genomics to Enable Dovetail Kits for the G4 Sequencing Platform

This partnership integrates G4’s accuracy, speed, flexibility and power with Dovetail’s expertise in 3-D genome architecture to empower specialized workflows for customers.LA JOLLA, Calif, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced a partnership with Dovetail Genomics to validate its proximity ligation kit portfolio,

Yahoo | January 10, 2022

Singular Genomics Partners with Watchmaker Genomics to Enable the Watchmaker DNA Library Prep Kits for the G4 Sequencing Platform

This partnership integrates G4’s accuracy, speed, flexibility and power with the Watchmaker DNA Library Prep Kits to empower innovative workflows for customersLA JOLLA, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced a partnership with Watchmaker Genomics to validate its Watchmaker DNA Library Prep Kits with Fragm

Yahoo | January 10, 2022

Singular Genomics Partners with Twist Bioscience to Enable the Twist NGS Target Enrichment Solutions for the G4 Sequencing Platform

This partnership integrates G4’s accuracy, speed, flexibility and power with the Twist target enrichment solutions to empower fixed and custom targeted sequencing panels for customers.LA JOLLA, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced a partnership with Twist Bioscience to validate its NGS Target Enrichment

Yahoo | January 10, 2022

Singular Genomics Partners with New England Biolabs® to Enable NEBNext® Kits for the G4 Sequencing Platform

This partnership integrates G4’s accuracy, speed, flexibility and power with the NEBNext DNA and RNA Library Prep Kits to empower high-quality, established workflows for customersLA JOLLA, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced a partnership with New England Biolabs (NEB®) to validate its NEBNext kits, a

Yahoo | January 10, 2022

Singular Genomics Systems, Inc. to Present at the 40th Annual J.P. Morgan Healthcare Conference

Management to Discuss the Launch of the G4 Sequencing PlatformLA JOLLA, Calif., Jan. 07, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced plans to present virtually at the 40th Annual J.P. Morgan Healthcare Conference. Singular Genomics’ management is scheduled to present virtually on Wednesday, January 12, 2022 at 1:30 p.m. Pacifi

Yahoo | January 7, 2022

Singular Genomics Appoints Genomics Research Pioneer Elaine R. Mardis, Ph.D., to Board of Directors

LA JOLLA, Calif., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced the addition of Elaine R. Mardis, Ph.D., to the Company’s Board of Directors. Dr. Mardis is a pioneering researcher internationally recognized in cancer genomics with a focus on the application of genomic technologies to improve the understanding of human d

Yahoo | January 6, 2022

Singular Genomics and Broad Institute Partner to Integrate Advanced Sequencing Technology with the Terra Data Platform

This partnership will help biomedical researchers access and analyze data from Singular Genomics systems and easily collaborate on the cloud using a secure, scalable and open source informatic platformLA JOLLA, Calif., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced the company is collaborating with the Broad Institute of

Yahoo | January 6, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4215 seconds.